No worries in the short term Stage 1 will play out. Long term.. "As a result, we believe that the immune response could be targeted to the entire repertoire of cancer antigen peptides produced by the cancer cell, rather than just to a single cancer antigen, as delivered by current cancer vaccines." Now that would be something. Lets see if they can back that up. Charts show a buy around 15 cents and so I do just that. -Invest no more than you can afford to loose
News 
Market Data 
Discover 
